SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $70,056,000 | -10.5% | 400,000 | 0.0% | 2.25% | -16.7% |
| Q3 2020 | $78,276,000 | +15.2% | 400,000 | 0.0% | 2.70% | -9.5% |
| Q2 2020 | $67,968,000 | +47.3% | 400,000 | 0.0% | 2.99% | -5.0% |
| Q1 2020 | $46,152,000 | -19.2% | 400,000 | -20.0% | 3.15% | -2.6% |
| Q4 2019 | $57,130,000 | +783.3% | 500,000 | +300.0% | 3.23% | +110.1% |
| Q2 2017 | $6,468,000 | +2.9% | 125,000 | +25.0% | 1.54% | +11.9% |
| Q1 2017 | $6,286,000 | +19.1% | 100,000 | 0.0% | 1.37% | -32.7% |
| Q4 2016 | $5,277,000 | -58.0% | 100,000 | -57.0% | 2.04% | -63.8% |
| Q3 2016 | $12,563,000 | +33.7% | 232,600 | 0.0% | 5.63% | -32.4% |
| Q2 2016 | $9,399,000 | +14.7% | 232,600 | -0.4% | 8.33% | +3.9% |
| Q1 2016 | $8,197,000 | +14.1% | 233,600 | +46.0% | 8.02% | +29.4% |
| Q4 2015 | $7,181,000 | – | 160,000 | – | 6.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |